More help

Find the latest and greatest treatment options near you

All
Emerging Treatments
Advanced Care
Clinical Trials
Research

NOCD PREMIUM

Feel better with the help of an OCD-trained therapist. It’s unlimited messaging, anytime and anywhere.

Emerging Treatments

A new option for treatment-resistant depression

We’re working with Actify Neurotherapies, a leading provider of ketamine treatment for depression that has not responded to previous treatment trials. Led by Dr. Steve Levine, Actify administers this cutting-edge treatment in a safe clinical setting.

Advanced Care

Get more care for OCD, PTSD, anxiety, addictions

Located just outside of Chicago, the Foglia Family Foundation Residential Treatment Center at AMITA Health offers holistic, evidence-based treatment programs. Their unique simultaneous treatment of multiple conditions is offered in intensive outpatient and residential settings.

Clinical Trials

A potential new medication for OCD

We’ve partnered with Biohaven Pharma on their clinical trial of an investigational medication that modulates glutamate, a neurotransmitter like serotonin. Participants may receive this medication, study-related psychiatric evaluations, and/or monetary compensation.

Research

What do people with OCD really obsess about?

In a new study, NOCD Scientific Advisors Jamie Feusner, MD, and Alex Leow, MD, PhD looked at clustering in symptom subtypes to determine the relationships between obsessions related to harm, sexual orientation, and other themes. Dr. Feusner and Dr. Leow used anonymized data from the NOCD app to source a large data set for this study.